These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon). RANDALL LO; BAGDON RE; ENGELBERG R Toxicol Appl Pharmacol; 1959 Jan; 1(1):28-37. PubMed ID: 13625313 [No Abstract] [Full Text] [Related]
5. The bacteriologicoclinical evaluation of 2,4-dimethoxy-6-sulfanilamido-1, 3-diazine (Madribon) in various urological disorders associated with urinary tract infection. SIERP M; DRAPER JW Ann N Y Acad Sci; 1959 Sep; 82():92-104. PubMed ID: 14446539 [No Abstract] [Full Text] [Related]
6. [Clinical experience with a new long-acting sulfonamide in pediatrics]. CARUGHI O Prensa Med Argent; 1959 May; 46():1157-60. PubMed ID: 13808065 [No Abstract] [Full Text] [Related]
7. The treatment of pneumonia and other infections with a soluble sulfonamide, gantrosan (NU-445; 3,4-dimethyl-5-sulfanilamido-isoxazole). BRICKHOUSE RL; LEPPER MH Am J Med Sci; 1949 Aug; 218(2):133-7. PubMed ID: 18135998 [No Abstract] [Full Text] [Related]
8. Sulphonamide or antibiotic? A clinical comparison. CALDWELL JR Med World; 1960 Sep; 93():220-1. PubMed ID: 13689932 [No Abstract] [Full Text] [Related]
9. [Infections of the biliary tract. Their treatment with a new long-acting sulfonamide]. LOPEZ ALEM JC Dia Med; 1959 Nov; 31():2230-4. PubMed ID: 14418217 [No Abstract] [Full Text] [Related]
10. [Experiences with the long-acting sulfonamide madribon]. SCHUETZE E Med Klin; 1959 Dec; 54():2339-41. PubMed ID: 14443725 [No Abstract] [Full Text] [Related]
11. Sulfaphenazol (orisul), a new, low dosage, long-acting sulfaonamide in otolaryngology. JACQUES AA; FUCHS VH Antibiotic Med Clin Ther (New York); 1959 Oct; 6():578-80. PubMed ID: 14406464 [No Abstract] [Full Text] [Related]
12. [Anti-infectious therapy, rational use, complications and accidents]. MONNET P J Med Lyon; 1961 Jun; 42():967-80. PubMed ID: 13772046 [No Abstract] [Full Text] [Related]
13. [Clinical and experimental results with the new long-acting sulfonamide Durenat]. LOHMEYER H; GOTHE D Med Klin; 1961 Nov; 56():2000-3. PubMed ID: 14466337 [No Abstract] [Full Text] [Related]
14. A new long-acting antibacterial sulfonamide, 2,4-dimethoxy-6-sulfanilamido-1,3-diazine: a comparative study. BOGER WP Antibiot Annu; 1958-1959; 6():48-55. PubMed ID: 13637707 [No Abstract] [Full Text] [Related]
15. [Some practical remarks on the subject of present-day purulent infections]. GAILLOUD C Rev Med Suisse Romande; 1962 Jun; 82():384-91. PubMed ID: 13896229 [No Abstract] [Full Text] [Related]
16. Preliminary report on a new long-acting sulphonamide. LEWIN MC Br J Urol; 1960 Sep; 32():324-6. PubMed ID: 13761670 [No Abstract] [Full Text] [Related]
17. [Experience with a new long-acting sulfonamide in vaginal surgery]. VINAS URQUIZA S Sem Med; 1960 May; 116():956-8. PubMed ID: 13842333 [No Abstract] [Full Text] [Related]
18. Sulfamethoxypyridazine: preliminary observations on absorption and excretion of a new, long-acting antibacterial sulfonamide. FINLAND M; JONES WF; NICHOLS RL Proc Soc Exp Biol Med; 1956 Jul; 92(3):637-40. PubMed ID: 13359491 [No Abstract] [Full Text] [Related]
19. Clinical results with sulfadimethoxine (madribon); a new long action antibacterial. MOSELY MJ J Natl Med Assoc; 1959 Jul; 51(4):258-62. PubMed ID: 13665342 [No Abstract] [Full Text] [Related]
20. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide. CESANA A; VENTURA R Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775 [No Abstract] [Full Text] [Related] [Next] [New Search]